| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $29,286 | 2 | 100 |
| Rona Jeffrey A | CBFO | 0 | $0 | 1 | $12,384 | $-12,384 |
| ALEXANDER MARGARET A. | President and CEO | 0 | $0 | 1 | $16,901 | $-16,901 |
Ovid Therapeutics Inc. is a biopharmaceutical firm dedicated to creating significant treatments for individuals and families impacted by neurological disorders across the United States. The company's robust pipeline features several key therapeutic candidates: OV101, a drug candidate currently undergoing Phase 2A clinical trials for Fragile X syndrome; OV329, an inhibitor targeting GABA aminotransferase, aimed at managing seizures linked to tuberous sclerosis complex and infantile spasms; and OV350, a small molecule developed to address various …
Over the last 12 months, insiders at Ovid Therapeutics Inc. have bought $0 and sold $29,286 worth of Ovid Therapeutics Inc. stock.
On average, over the past 5 years, insiders at Ovid Therapeutics Inc. have bought $27,668 and sold $17,214 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 6,810 shares for transaction amount of $4,971 was made by ALEXANDER MARGARET A. (President and COO) on 2025‑01‑27.
| 2026-02-23 | Sale | Rona Jeffrey A | CBFO | 8,541 0.012% | $1.45 | $12,384 | +71.38% | |
| 2026-02-23 | Sale | ALEXANDER MARGARET A. | President and CEO | 11,656 0.0164% | $1.45 | $16,901 | +71.38% | |
| 2025-02-26 | Sale | ALEXANDER MARGARET A. | President and COO | 5,279 0.0079% | $0.56 | $2,956 | +115.73% | |
| 2025-02-26 | Sale | Rona Jeffrey A | CBFO | 3,902 0.0058% | $0.56 | $2,185 | +115.73% | |
| 2025-01-27 | ALEXANDER MARGARET A. | President and COO | 6,810 0.0096% | $0.73 | $4,971 | -9.40% | ||
| 2024-03-18 | LEVIN JEREMY M | CEO | 18,248 0.0261% | $2.76 | $50,364 | -59.52% | ||
| 2021-07-14 | Sale | Rakhit Amit | President and CMO | 34,017 0.0508% | $3.71 | $126,203 | -10.93% | |
| 2020-08-28 | LEVIN JEREMY M | CEO | 8,488 0.0143% | $5.84 | $49,570 | -33.90% | ||
| 2019-10-08 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 2M 4.1699% | $2.50 | $5M | +65.16% | ||
| 2019-10-08 | LEVIN JEREMY M | CEO | 60,000 0.1251% | $2.50 | $150,000 | +65.16% | ||
| 2019-02-26 | Bernstein Karen | director | 10,000 0.0325% | $2.02 | $20,210 | +7.32% | ||
| 2019-02-22 | LEVIN JEREMY M | CEO | 75,000 0.2617% | $2.00 | $150,000 | +15.34% | ||
| 2018-08-14 | Bernstein Karen | director | 20,000 0.0386% | $3.12 | $62,300 | -60.76% | ||
| 2018-08-14 | WILLIAMS DOUGLAS E | director | 10,000 0.0201% | $3.24 | $32,442 | -60.76% | ||
| 2017-08-25 | LEVIN JEREMY M | CEO | 30,668 0.062% | $3.58 | $109,638 | +20.31% |
| ALEXANDER MARGARET A. | President and CEO | 61750 0.0316% | $148,200.00 | 1 | 2 | <0.0001% |
| TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 5750000 2.9442% | $13.8M | 1 | 0 | +65.16% |
| LEVIN JEREMY M | CEO | 3616715 1.8519% | $8.68M | 5 | 0 | +33.6% |
| Bernstein Karen | director | 20000 0.0102% | $48,000.00 | 2 | 0 | <0.0001% |
| WILLIAMS DOUGLAS E | director | 5000 0.0026% | $12,000.00 | 1 | 0 | <0.0001% |
$3,887,391 | 114 | 13.01% | $433.37M | |
$40,226,318 | 58 | 18.89% | $539.26M | |
$24,384,691 | 42 | -30.27% | $396.82M | |
$16,169,789 | 40 | 7.44% | $485.1M | |
$2,481,409 | 33 | 201.68% | $455.48M |
| Increased Positions | 47 | +50% | 42M | +145.55% |
| Decreased Positions | 39 | -41.49% | 8M | -29.24% |
| New Positions | 21 | New | 28M | New |
| Sold Out Positions | 13 | Sold Out | 3M | Sold Out |
| Total Postitions | 102 | +8.51% | 62M | +116.31% |
| Vanguard Group Inc | $4,965.00 | 3.97% | 2.82M | +184,698 | +7.01% | 2025-09-30 |
| Affinity Asset Advisors, Llc | $4,664.00 | 3.73% | 2.65M | +2M | +296.99% | 2025-09-30 |
| Acadian Asset Management Llc | $4,024.00 | 3.22% | 2.29M | +178,169 | +8.45% | 2025-09-30 |
| Renaissance Technologies Llc | $3,552.00 | 2.84% | 2.02M | -77,285 | -3.69% | 2025-09-30 |
| Sio Capital Management, Llc | $2,512.00 | 2.01% | 1.43M | -804,505 | -36.04% | 2025-09-30 |
| Driehaus Capital Management Llc | $2,464.00 | 1.97% | 1.4M | 0 | 0% | 2025-09-30 |
| Adage Capital Partners Gp, L.L.C. | $2,376.00 | 1.9% | 1.35M | +200,000 | +17.39% | 2025-09-30 |
| Kennedy Capital Management Llc | $1,948.00 | 1.56% | 1.11M | -395,691 | -26.34% | 2025-09-30 |
| Ikarian Capital, Llc | $1,928.00 | 1.54% | 1.1M | +1M | New | 2025-09-30 |
| Millennium Management Llc | $1,736.00 | 1.39% | 986,293 | -66,041 | -6.28% | 2025-09-30 |